MASS
908 Devices Inc

1,021
Mkt Cap
$213.9M
Volume
424,919.00
52W High
$9.34
52W Low
$1.81
PE Ratio
-3.61
MASS Fundamentals
Price
$6.18
Prev Close
$5.91
Open
$5.93
50D MA
$7.60
Beta
1.54
Avg. Volume
309,674.13
EPS (Annual)
-$2.12
P/B
1.64
Rev/Employee
$242,402.44
Loading...
Loading...
News
all
press releases
Mitsubishi UFJ Asset Management Co. Ltd. Purchases New Holdings in 908 Devices Inc. $MASS
Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) in the second quarter, according to the company in its most recent 13F filing...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Leerink Partnrs Increases Earnings Estimates for 908 Devices
908 Devices Inc. (NASDAQ:MASS - Free Report) - Analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for 908 Devices in a research report issued on Monday, November 10th...
MarketBeat·11d ago
News Placeholder
908 Devices (NASDAQ:MASS) Issues Quarterly Earnings Results
908 Devices (NASDAQ:MASS - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.03...
MarketBeat·13d ago
News Placeholder
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of -15.38% and +3.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported...
Business Wire·15d ago
News Placeholder
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
Sight Sciences (SGHT) delivered earnings and revenue surprises of +38.46% and +15.98%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?
Envoy Medical, Inc. (COCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·19d ago
News Placeholder
Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates
Penumbra (PEN) delivered earnings and revenue surprises of +7.78% and +4.12%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of 0.00% and +31.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·22d ago

Latest MASS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.